{{Rsnum
|rsid=6966
|Gene=PPP1R13L
|Chromosome=19
|position=45379704
|Orientation=minus
|GMAF=0.3747
|Gene_s=PPP1R13L
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 72.1 | 24.3 | 3.6
| HCB | 29.9 | 48.2 | 21.9
| JPT | 29.2 | 54.9 | 15.9
| YRI | 6.8 | 39.5 | 53.7
| ASW | 19.3 | 49.1 | 31.6
| CHB | 29.9 | 48.2 | 21.9
| CHD | 26.9 | 53.7 | 19.4
| GIH | 52.5 | 43.6 | 4.0
| LWK | 10.1 | 44.0 | 45.9
| MEX | 50.0 | 44.8 | 5.2
| MKK | 14.8 | 45.8 | 39.4
| TSI | 63.4 | 32.7 | 4.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22351191
|Title=Hapmap-based evaluation of ERCC2, PPP1R13L, and ERCC1 and lung cancer risk in a Chinese population
}}

{{PMID Auto
|PMID=18709642
|Title=Nucleotide excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African Americans.
|OA=1
}}

{{PMID Auto
|PMID=24604828
|Title=Focused screening of a panel of cancer-related genetic polymorphisms reveals new susceptibility loci for pediatric acute lymphoblastic leukemia
}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}